Mike Verneris, MD, was already a familiar face at the Gates Biomanufacturing Facility when he was named Medical Director in 2025. He has extensive experience as both a scientific lead and clinical principal investigator in numerous cell therapy trials at University of Colorado Anschutz. Dr. Verneris also serves in leadership roles for the Gates Institute, as well as the CU School of Medicine and CU Cancer Center. Dr. Verneris’ clinical research expertise is informed by his role as a physician at Children’s Hospital Colorado and is the director of Bone Marrow Transplant and Cellular Therapy for the hospital’s Center for Cancer and Blood Disorders.

Dr. Verneris received a medical degree from the Dartmouth-Brown Program in Medicine and completed a pediatric internship and residency at Children’s National Medical Center, followed by a pediatric hematology/oncology fellowship at Stanford University and a post-doctoral fellowship at the Stanford University Division of Bone Marrow Transplant.